Regeneron beats Q2 estimates as Dupixent sales drive growth

source:

[1] Regeneron (REGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (https://www.zacks.com/stock/news/2964735/rege ...)[2] REGN Regeneron Pharmaceuticals, Inc. (https://seekingalpha.com/symbol/REGN/news ...)[3] Stock market today: Dow, S&P 500, Nasdaq rebound after Fed decision, as Microsoft leads tech gains (https://www.msn.com/en-us/money/markets/stock ...)[4] Biogen outlines 2026 non-GAAP EPS $12-$13 and expects SYFOVRE and EMPAVELI mid- to high teens growth through at least 2028 (https://seekingalpha.com/news/4620801-biogen- ...)[5] Regeneron beats second-quarter expectations as Dupixent growth fuels strong results (https://www.msn.com/en-us/money/general/regen ...)

Related News

Jul 30 2026, 17:24

Cimpress misses Q4 estimates as revenue falls 2% short of consensus

Jul 30 2026, 17:24

Masco beats Q2 EPS estimates by 23% as revenue falls short

Masco posted Q2 earnings of $1.64 a share, topping estimates by 23%, while revenue of $1.99B missed consensus. The mixed results reflect a company that has successfully managed costs but faces demand headwinds in its core home improvement markets. Masco's ability to beat EPS estimates by $0.31 came despite a revenue shortfall of roughly $110 million against the $2.10 billion consensus, showing the effectiveness of its margin-focused strategy. | Metric | Actual | Consensus | Beat/Miss | |--------|--------|-----------|-----------| | EPS | $1.64 | $1.33 | +$0.31 (+23%) | | Revenue | $1.99B | $2.10B | -$109.8M (-5.2%) | Revenue of $1.99 billion for the quarter ended June 27 represents the company's performance across its two main segments: plumbing products, which includes brands like Delta and Moen, and decorative architectural products, which includes Behr paint. The company did not disclose segment-level breakdowns, year-over-year comparisons, or updated full-year guidance in its initial release. Analysts had modeled for modest growth in plumbing and stable paint demand, but the top-line miss suggests softer-than-expected volumes across both categories. The revenue shortfall of 5.2% against consensus marks a reversal from the prior quarter, when Masco's top line came in closer to expectations. The 23% EPS beat shows that margin discipline helped offset the revenue weakness. Masco has benefited from restructuring initiatives and supply chain improvements implemented over the past two years, which have helped protect profitability even as volumes softened in a high-rate environment. The company's focus on operational efficiency appears to have insulated earnings from the broader slowdown in home improvement spending affecting peers such as Fortune Brands Innovations and Stanley Black & Decker. Gross margin expansion, driven by lower raw material costs and manufacturing efficiencies, has been a key driver of the earnings outperformance. The mixed quarter leaves Masco navigating a housing market where elevated borrowing costs continue to suppress the repair and remodel activity that drives demand for its products. Existing home sales have remained subdued, reducing the renovation projects that typically follow a home purchase. The National Association of Realtors reported that existing home sales in June fell to a seasonally adjusted annual rate below 4 million, the lowest level in months, directly impacting demand for Masco's plumbing fixtures and paint products. Investors will watch for management's commentary on second-half demand trends and any updates to the company's cost reduction targets when Masco holds its earnings call. The stock's reaction in the coming session will provide the first market read on whether the EPS beat outweighs the revenue miss, with the company's ability to sustain margins through a demand downturn being the central question. A rate cut from the Federal Reserve later this year could provide a tailwind for the housing market and, by extension, Masco's revenue trajectory. This article is for informational purposes only and does not constitute investment advice.

Jul 30 2026, 17:14

Related News

Cimpress misses Q4 estimates as revenue falls 2% short of consensus

Masco beats Q2 EPS estimates by 23% as revenue falls short

Watsco misses Q2 estimates as revenue falls short of $2.17B consensus